Intrinsic Value of S&P & Nasdaq Contact Us

Curative Biotechnology, Inc. CUBT OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
27/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — CUBT

Curative Biotechnology, Inc. (CUBT) has a market capitalization of $7.87M and trades at $1.10. The 52-week range is 0.003-1.79.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -275, Earnings Per Share (EPS) of $0.00.

The stock has a beta of 1.42, operates in the Healthcare sector.

Trading Data
Current Price$1.10
52-Week Range0.003-1.79
Volume1.94K
Avg Volume (30D)246.29K
Market Cap$7.87M
Beta (1Y)1.42
Company
IPO Date1998-03-30
Employees4
CEOI. Richard Garr
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS23128N1081
CUSIP23128N108
Income (Latest Year)
Gross Profit$-92.21K
EBITDA$-2.35M
Operating Income$-2.44M
Net Income$-3.57M
EPS$0.00
EPS Diluted$0.00
Shares Outstanding$907.91M
Balance Sheet (Latest Year)
Total Assets$2.16M
Current Assets$211.89K
Cash & ST Investments$19.53K
Total Liabilities$7.08M
Total Debt$1.37M
Net Debt$1.35M
Total Equity$-4.91M
Debt / Equity-0.28
Valuation Ratios
P/E Ratio-275
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message